PENTIXAPHARM HOLDING N AG Market Cap ($922.50K)
Market Cap & Net Worth: PENTIXAPHARM HOLDING N AG (PTP)
PENTIXAPHARM HOLDING N AG market cap. PENTIXAPHARM HOLDING N AG (XETRA:PTP) has a market capitalization of $922.50K (€789.07K) as of November 4, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #30741 globally and #2686 in its home market, demonstrating a 0.87% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PENTIXAPHARM HOLDING N AG's stock price €1.74 by its total outstanding shares 500000 (500.00K). Also see PTP operating cash flow for how efficiently the company converts equity into cash flow.
PENTIXAPHARM HOLDING N AG Market Cap History (2024–2026)
PENTIXAPHARM HOLDING N AG market cap history from 2024 to 2026. Data shows change from $1.72 Million to $1.02 Million (-36.23% CAGR). Check PTP stock price and chart for real-time trading data and today's change.
PENTIXAPHARM HOLDING N AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PENTIXAPHARM HOLDING N AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore PENTIXAPHARM HOLDING N AG (PTP) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
9.32x
PENTIXAPHARM HOLDING N AG's market cap is 9.32 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.72 Million | $118.00K | -$12.84 Million | 14.61x | N/A |
| 2025 | $866.31K | $93.00K | -$16.51 Million | 9.32x | N/A |
Competitor Companies of PTP by Market Capitalization
Companies near PENTIXAPHARM HOLDING N AG in the global market cap rankings as of November 4, 2026. Also see PTP current and non-current assets for a full breakdown of the balance sheet.
Key companies related to PENTIXAPHARM HOLDING N AG by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of PENTIXAPHARM HOLDING N AG (2024–2026)
Market capitalization of PENTIXAPHARM HOLDING N AG from 2024 to today. Between 2024 and today, PENTIXAPHARM HOLDING N AG's market cap moved from $1.72 Million to $ 1.02 Million, with a yearly change of -36.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.02 Million | +17.41% |
| 2025 | €866.31K | -49.76% |
| 2024 | €1.72 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of PENTIXAPHARM HOLDING N AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $922.50K USD |
| MoneyControl | $922.50K USD |
| MarketWatch | $922.50K USD |
| marketcap.company | $922.50K USD |
| Reuters | $922.50K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PENTIXAPHARM HOLDING N AG
Pentixapharm Holding AG, a clinical-stage biopharmaceutical company, develops radiopharmaceuticals. The company focuses on developing CXCR4 binding, peptide-based technology, which includes PentixaFor (PT-001), a tracer based on Gallium-68, used to diagnose and monitor the progress of various diseases, including hematological and solid tumors, as well as endocrine, cardiovascular, and immunologic… Read more